More Definitive Evidence Carves Out LVEF Zone for Beta-Blockers After MI

By News Health
1 month Ago

(MedPage Today) — MADRID — Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.
Putting aside their known…

Source link : https://www.medpagetoday.com/meetingcoverage/esc/117245

Author :

Publish date : 2025-08-31 17:54:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Is Tylenol Linked to Infant Eczema?

Antibody Prevention of RSV in Infants; Medical Imaging and Cancer Risk in Kids

Trusted Vaccine Guidance Has Collapsed — Along With the Rule of Law

Considering GLP-1 Agonists for Patients With Psoriasis, HS

It's Time to Get a Flu Vaccination. Here's Who Needs One and Why.

Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say